In this final interview clip, Michael A. Bernstein, MD, stresses the need for effective communication and proactive screening ...
The lead investigator for EV-302 said not long ago, survival of 12 to 14 months in this type of bladder cancer was considered ...
Investigators from Shanghai, China, report responses above 90% by using levantinib and tislelizumab to treat patients with a ...
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...